Nouvelles - Bioventus

mars 11, 2021

Bioventus Reports First Patients Enrolled in Phase 1 Clinical Trial of MOTYS(TM) (PTP-001) for the Treatment of Knee OA

DURHAM, NC – March 11, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a leader in solutions for innovative healing, reported…

mars 4, 2021

Larry Chen Joins Bioventus as Managing Director, China and Asia Pacific

DURHAM, NC – March 4, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, has…

mars 1, 2021

Bioventus to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 25, 2021

DURHAM, NC – March 1, 2021 – Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today…

février 10, 2021

Bioventus Announces Pricing of Initial Public Offering

DURHAM, NC – February 10, 2021 – Bioventus Inc. ("Bioventus" or the “Company”) today announced the pricing of its initial public offering of…

février 4, 2021

Bioventus Announces Launch of Initial Public Offering

DURHAM, NC – February 4, 2021 – Bioventus Inc. ("Bioventus" or the “Company”), today announced that it has commenced the initial public offering of…

janvier 19, 2021

Miguel O. Beltrán-Delgado Joins Bioventus as Senior Vice President of Operations

DURHAM, NC – January 19, 2021 – Bioventus, a global leader in Innovations For Active Healing, has appointed Miguel O. Beltrán-Delgado as Senior Vice…

novembre 18, 2020

Bioventus Receives Authorization to Proceed Under Investigational New Drug Application for Clinical Trial of Placental Tissue Particulate (PTP-001) for the Treatment of Knee OA

DURHAM, NC – November 18, 2020 – Bioventus, a leader in Solutions For Innovative Healing, received authorization to proceed under its investigational…

novembre 16, 2020

Bioventus Appoints Chris Yamamoto Senior Vice President of Business Development and Strategy

DURHAM, NC – November 16, 2020 – Bioventus, a global leader in Innovations For Active Healing, has appointed Chris Yamamoto as Senior Vice President…

novembre 10, 2020

Bioventus to Provide CVS Caremark with its Portfolio of Preferred Options for Knee Osteoarthritis Patients Seeking Pain Relief

DURHAM, NC – November 10 – Beginning January 1, 2021 Bioventus, a global leader in Innovations For Active Healing, will gain preferred access through…

septembre 22, 2020

Bioventus Reaches Milestone with 2 Million DUROLANE® Treatments Worldwide

DURHAM, NC – September 22, 2020 – Bioventus, a global leader in Innovations For Active Healing, is celebrating a milestone and recognizing more than…

Salle de presse

Recherche sur les nouvelles

Bibliothèque de téléchargement